Owing to its pivotal role in inflammatory conditions, IL-11 has been investigated as a therapeutic candidate for rheumatoid arthritis, Crohn’s disease, refractory immune thrombocytopenic purpura, and periodontal disease [23]. This evidence concerns the gene IL11 and Crohn disease.